Physician profile
Matthew J Sullivan
NPI 1306282793
$1,927.17
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $930 · 2020: $125 · 2021: $342 · 2022: $249 · 2023: $125 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $343.99 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.69 | 2020-2021 | |
| Abbvie INC. | $240.93 | 2019-2023 | Skyrizi |
| Allergan, INC. | $232.06 | 2019 | |
| Braintree Laboratories, INC. | $155.85 | 2024 | Suflave, Sutab |
| Pfizer INC. | $124.80 | 2019 | |
| Gilead Sciences, INC. | $124.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $124.74 | 2022 | |
| Covidien LP | $116.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $114.77 | 2019 | |
| Boston Scientific Corporation | $51.22 | 2019 | |
| Shire North American Group INC | $50.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.